+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nitazoxanide"

Antiparasitic Drugs Market Report 2025 - Product Thumbnail Image

Antiparasitic Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2025 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Nitazoxanide is a broad-spectrum antiparasitic and antiviral drug used to treat a variety of infectious diseases. It is a nitrothiazolyl salicylamide derivative and is active against protozoa, helminths, and viruses. It is used to treat infections caused by Giardia lamblia, Cryptosporidium parvum, Entamoeba histolytica, and other protozoa, as well as infections caused by nematodes and trematodes. It is also used to treat viral infections such as rotavirus, norovirus, and adenovirus. Nitazoxanide is available in tablet, suspension, and film-coated tablet forms. It is generally well tolerated, with the most common side effects being nausea, vomiting, and abdominal pain. Nitazoxanide is marketed by several companies, including Alinia Pharmaceuticals, Inc., Cipla Limited, and Zydus Cadila. Show Less Read more